论文部分内容阅读
Ezetimibe(ET)是一种新的胆固醇吸收抑制剂,Atorvastatin(AV)属于HMG-CoA(3-羟-3-甲基戊二酸-辅酶A)还原酶抑制剂。研究表明,二者联合使用可以高效治疗高胆固醇血症患者,并且患者耐受性良好。 美国休斯顿市Baylor医学院的Dr.Ballantyne及其同事们对628名原发性高胆固醇血症患者进行了联合用
Ezetimibe (ET) is a novel cholesterol absorption inhibitor and Atorvastatin (AV) belongs to HMG-CoA (3-hydroxy-3-methylglutarate-coenzyme A) reductase inhibitor. Studies have shown that the combination of the two can be highly effective in patients with hypercholesterolemia, and patients with good tolerance. Dr. Ballantyne and colleagues at Baylor College of Medicine in Houston, United States conducted a combined study of 628 patients with primary hypercholesterolemia